TY - JOUR
T1 - Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1
AU - Tomassetti, Antonella
AU - Coney, Leslie R.
AU - Canevari, Silvana
AU - Miotti, Silvia
AU - Facheris, Patrizia
AU - Zurawski, Vincent R.
AU - Colnaghi, Maria I.
PY - 1993/2/8
Y1 - 1993/2/8
N2 - The human ovarian carcinoma cell line, IGROV1, produces two forms of folate binding protein (FBP), the membrane form that is anchored to the cell surface by a glycosylphosphatidylinositol tail and the soluble form that is shed into the tissue culture medium. Both forms are recognized by the monoclonal antibodies MOv18 and MOv19. Here we describe their purification and biochemical characterization. The purified soluble protein appeared as a single band with an apparent Mr of 36 kDa after SDS-PAGE, whereas the membrane form appeared as a single band with an apparent Mr of 38 kDa. The size difference between the two forms of FBP was confirmed by gel filtration of both the native and the N-glycanase-treated proteins. Both purified proteins had equal capacity to bind folic acid. The immunological cross-reactivity and the folic acid binding capability of the FBPs extracted from IGROV1 gave more evidence of the possible existence of a precursor-product relationship between them.
AB - The human ovarian carcinoma cell line, IGROV1, produces two forms of folate binding protein (FBP), the membrane form that is anchored to the cell surface by a glycosylphosphatidylinositol tail and the soluble form that is shed into the tissue culture medium. Both forms are recognized by the monoclonal antibodies MOv18 and MOv19. Here we describe their purification and biochemical characterization. The purified soluble protein appeared as a single band with an apparent Mr of 36 kDa after SDS-PAGE, whereas the membrane form appeared as a single band with an apparent Mr of 38 kDa. The size difference between the two forms of FBP was confirmed by gel filtration of both the native and the N-glycanase-treated proteins. Both purified proteins had equal capacity to bind folic acid. The immunological cross-reactivity and the folic acid binding capability of the FBPs extracted from IGROV1 gave more evidence of the possible existence of a precursor-product relationship between them.
KW - Folate binding protein
KW - Glycosylphosphatidylinositol linkage
KW - Ovarian carcinoma
UR - http://www.scopus.com/inward/record.url?scp=0027464683&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027464683&partnerID=8YFLogxK
U2 - 10.1016/0014-5793(93)81510-7
DO - 10.1016/0014-5793(93)81510-7
M3 - Article
C2 - 8428622
AN - SCOPUS:0027464683
VL - 317
SP - 143
EP - 146
JO - FEBS Letters
JF - FEBS Letters
SN - 0014-5793
IS - 1-2
ER -